| Metric | შპს Linema Pharm | შპს ალტა ფარმა | შპს ნ-ფარმა |
|---|---|---|---|
| Growth | |||
| Revenue | ₾3.9m₾1.6m | ₾3.5m₾2.9m | ₾5.1m₾5.4m |
| Revenue growth | 139.8% | 18.8% | -4.7% |
| Profitability | |||
| EBITDA | ₾1.2m₾465k | ₾1.6m₾1.4m | ₾1.8m₾1.9m |
| EBITDA margin | 31.0%28.7% | 45.9%46.7% | 34.8%36.0% |
| Net profit | ₾1.2m-₾90k | ₾1.5m₾1.4m | |
| ₾1.6m₾1.8m |
| Net margin | 31.0%-5.5% | 43.2%46.7% | 31.7%34.2% |
| Balance sheet | |||
| Total assets | ₾7.5m₾6.2m | ₾2.8m₾1.5m | ₾4.7m₾4.4m |
| Total equity | ₾6.4m₾5.4m | ₾2.7m₾1.3m | ₾3.9m₾3.1m |
| ROE | 18.9%-1.6% | 55.4%105.6% | 41.9%59.1% |